Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Consolidated Diluted EPS At 0.7305

0

For the year ended 2015-12-31 Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) basic consolidated EPS came $0.7559. Furthermore, for the quarter closed 2015-12-31, it was $0.7559.

Consolidated diluted EPS

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) consolidated diluted EPS was 0.7305 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it stood at $0.7305.

EPS contribution from parent

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) basic EPS was $0.7559 for the year ended 2015-12-31 from its parent entity. It was $0.7559 for the quarter closed 2015-12-31.

EPS from continuing operations

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) EPS from continuing activities was $0.7559 for the fiscal ended 2015-12-31. For the quarter ended 2015-12-31, this figure was $0.7559.

Basic net EPS

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) basic net EPS was $0.76 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it came at $0.76.

Diluted EPS from parent

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) diluted EPS from parent entity came at $0.7305 for the year ended 2015-12-31. For the quarter ended 2015-12-31 it was $0.7305.

Net diluted EPS

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) net diluted EPS was $0.73 for the fiscal closed 2015-12-31. For the quarter ended 2015-12-31, net diluted EPS was $0.73.

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) net basic EPS was $0.76 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it was $0.76.

Basic diluted EPS

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) basic diluted EPS was $-0.0954 for the quarter ended 2015-12-31. For the year ended 2015-12-31, basic diluted EPS was $-0.0954.

For the year ended 2015-12-31, basic shares outstanding were 44.15 while for the quarter ended 2015-12-31 is 44.15.

For the fiscal ended 2015-12-31, the diluted outstanding shares were 45.68 and for the quarter ended 2015-12-31 it was 45.68. Earnings per share and diluted EPS are profitability metrics used in fundamental analysis of firms. EPS just takes into account a firm’s common shares, while diluted EPS considers all convertible securities. Per-share earnings measure the quantum of a company’s earnings on a per share basis. Basic EPS does not consider any dilutive impact that convertible securities leave on EPS. On contrary, diluted EPS is a tool used in fundamental study to gauge a firm’s quality of EPS, assuming there is conversion of all convertible securities.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 12 times, 1 visits today)